Business / Finance

RSS

Rainbow Biosciences signs letter of intent to form new joint venture with n3D

Rainbow Biosciences, a division of Rainbow Coral Corp. announced today that it signed a letter of intent to acquire or form a new joint venture with cutting-edge biotech firm n3D Biosciences, Inc.

12 Dec 2011

ICON agrees to acquire BeijingWits

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting Ltd., a leading CRO in China.

12 Dec 2011

QSI enters agreement to acquire ViaTrack

Quality Systems, Inc., a leading provider of healthcare information systems and connectivity solutions, today announced that it has entered into an agreement to acquire ViaTrack Systems, a developer and provider of information technologies that enhance electronic data interchange (EDI) offerings.

12 Dec 2011

Exact Sciences completes underwritten public offering of common stock

Exact Sciences Corp. today announced that it has completed its previously announced underwritten public offering of its common stock at a price of $8.00 per share to the public.

12 Dec 2011

Cubist, Adolor announce results of initial tender offer

Cubist Pharmaceuticals, Inc. and Adolor Corporation today announced the results of Cubist's initial tender offer to purchase all of the outstanding shares of common stock of Adolor.

8 Dec 2011

OUP announces acquisition of two journal titles from Preston Publications

Oxford University Press (OUP) is pleased to announce the acquisition of two titles, Journal of Analytical Toxicology (JAT) and Journal of Chromatographic Science (JCS), from Preston Publications, in a transaction managed by DeSilva+Phillips.

8 Dec 2011

Senators say burden on Express Scripts and Medco to show merger would benefit consumers, competition

Sen. Herb Kohl on Tuesday told Express Scripts and Medco executives that the burden was "squarely" on them to show that their proposed $29 billion merger would benefit consumers and competition, not just the corporate bottom line.

8 Dec 2011

Business of Health: Iowa companies merging, 'rapid' growth for Mass. for-profit chain

In Iowa, two nonprofit nursing services are joining, and in Mass., Steward Health Care System's growth is worrying community hospitals.

7 Dec 2011

Landauer fourth quarter revenue increases 5.3% to $120.5 million

Landauer, Inc., a recognized leader in personal and environmental radiation monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2011 fourth quarter and year ended September 30, 2011.

6 Dec 2011

MSD establishes Asia Research & Development headquarters in Beijing

Merck & Co., Inc., known as MSD outside the United States and Canada, today announced the establishment of an Asia Research & Development (R&D) headquarters for innovative drug discovery and development located in Beijing, China.

6 Dec 2011

Tyco International acquires Visonic

Tyco International Ltd. announced today that the company has completed the acquisition of Visonic Ltd., a global developer and manufacturer of electronic security systems and components, for approximately $100 million in cash. The acquisition was first announced on September 15, 2011.

6 Dec 2011

Roche signs agreement to acquire Verum Diagnostica

Roche announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany.

From Roche Sequencing and Life Science 6 Dec 2011

MRG releases 2012 report on European markets for large-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for large-joint reconstructive implants will grow moderately through 2016.

5 Dec 2011

Wolters Kluwer Health announces acquisition of STM journal publisher in India, Medknow

Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world.

5 Dec 2011

Unigene acquires exclusive worldwide rights to oral PTH program from GSK

Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.

5 Dec 2011

Hi-Tech Pharmacal second quarter net sales increase 27% to 56,875,000

Hi-Tech Pharmacal Co., Inc. today reported results for the Company's fiscal second quarter ended October 31, 2011.

5 Dec 2011

InfraReDx receives $10M senior secured multi-draw term loan from GE Capital

GE Capital, Healthcare Financial Services announced today that it was the sole lender on a $10 million senior secured multi-draw term loan to InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases. The financing will be used to help support product commercialization efforts.

5 Dec 2011

Acadia prices 8.3 million public offering

Acadia Healthcare Company, Inc. today announced a public offering of 8,333,333 shares of its common stock, pursuant to a registration statement filed with the Securities and Exchange Commission.

5 Dec 2011

Millipore reports redemption completion of outstanding 3.75% Convertible Senior Notes Due 2026

Millipore Corporation, the Life Science business of Merck KGaA of Germany, that operates as EMD Millipore in the U.S. and Canada, today announced that all its remaining outstanding 3.75% Convertible Senior Notes Due 2026 (the "Notes") were redeemed on December 1, 2011, at one hundred percent (100%) of the outstanding principle amount of the Notes.

3 Dec 2011

Pfizer acquires Excaliard

Pfizer Inc. announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.

3 Dec 2011